This topic contains a solution. Click here to go to the answer

Author Question: According to research, a person with schizophrenia who exhibits flat affect a. is incapable of ... (Read 31 times)

genevieve1028

  • Hero Member
  • *****
  • Posts: 601
According to research, a person with schizophrenia who exhibits flat affect
 
  a. is incapable of experiencing emotion.
  b. can display emotion at certain times.
  c. is capable of experiencing emotion.
  d. none of the above

Question 2

A research study involving adults with schizophrenia looked at their facial expressions in home movies taken when they were children. The researchers were trying to determine if the development of schizophrenia could be predicted by facial expressions showing limited emotional reactions. This research study focused on the negative symptom called
 
  a. alogia.
 b. affective flattening.
 c. associative splitting.
 d. emotional effect syndrome.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

dantucker

  • Sr. Member
  • ****
  • Posts: 346
Answer to Question 1

c

Answer to Question 2

b





 

Did you know?

The average person is easily confused by the terms pharmaceutics and pharmacology, thinking they are one and the same. Whereas pharmaceutics is the science of preparing and dispensing drugs (otherwise known as the science of pharmacy), pharmacology is the study of medications.

Did you know?

The modern decimal position system was the invention of the Hindus (around 800 AD), involving the placing of numerals to indicate their value (units, tens, hundreds, and so on).

Did you know?

The strongest synthetic topical retinoid drug available, tazarotene, is used to treat sun-damaged skin, acne, and psoriasis.

Did you know?

Methicillin-resistant Staphylococcus aureus or MRSA was discovered in 1961 in the United Kingdom. It if often referred to as a superbug. MRSA infections cause more deaths in the United States every year than AIDS.

Methicilli ...
Did you know?

The Food and Drug Administration has approved Risperdal, an adult antipsychotic drug, for the symptomatic treatment of irritability in children and adolescents with autism. The approval is the first for the use of a drug to treat behaviors associated with autism in children. These behaviors are included under the general heading of irritability and include aggression, deliberate self-injury, and temper tantrums.

For a complete list of videos, visit our video library